Intercepting FUT8 transcription by STAT3 inhibitor, Stattic, significantly deduce glycosylation PD-L2 protein level and thus decreases proliferation and resistance to cetuximab and EGFR inhibitors in HNSCC [23]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.